European Archives - Page 532 of 1101 - European Medical Journal

How to avoid alienation during digital upskilling

To do well at digital transformation, pharma leaders must balance skills development with maintaining employee morale.

Melinta Therapeutics’s Christine Miller on being fuelled by purpose

Christine Miller is the President, Chief Executive Officer, and member of the board, Melinta Therapeutics, speaks to us about her path into the pharmaceutical industry, her mission to end antimicrobial resistance, and how to be an effective leader in pharma today

Navigating launch challenges for an improved patient journey

Amidst an ever-changing launch landscape, the COVID-19 pandemic has entirely disrupted the pharmaceutical industry, encouraging adaptation for success. By understanding the transformed patient journey, leveraging digital campaigns, and innovating in healthcare marketing strategies, how can pharma find new avenues for launch success?

A joint mission for social justice

Social justice is a rising priority for all industries, but particularly for the pharmaceutical sector in the wake of COVID-19 and the social inequities it unveiled. We look at how the industry is increasingly working alongside the world’s top advertising agencies to promote growth from good in their activities.

How can medical affairs lead the way in neurology?

Neurological conditions are complex and require a high level of expertise and sensitivity, making them an juicy area for medical affairs teams. How do the challenges shape the MA role in this space and how is the landscape evolving?

A breakdown of pharma's reputation

This infographic tracks the evolution of the industry’s reputation by breaking down the perspectives of individual countries and generations, while also examining the impact of the COVID-19 pandemic on public outlook.

SARS-CoV-2 and Cystic Fibrosis: Expectations Versus Reality, a Literature Review

Cystic fibrosis (CF) is a chronically deteriorating lung condition that can affect multiple systems, frequently accompanied by…

An Aesthetic Alliance

In this podcast, we navigate the nuances of aesthetic surgery, explore what a holistic and patient-centric approach truly means, discuss the partnership of doctor and patient-centric approach truly means, discuss the partnership of doctor and nurse, and share their experiences of integrating work and married life.

The Benefits of Genomic Microarray in the Age of NGS

In this podcast, discover the continuing advantages of chromosomal microarray in cytogenetics. Jonathan sits down with Dr Shashi Shetty, Director of Cytogenetics Laboratory, Cleveland Medical Centre, Cleveland, Ohio, to explore at what point microarrays are the preferred choice for genetic research testing in the age of next generation sequencing (NGS).

Into the Flow #2: AKI Prevention with RenalGuard

This week’s episode is a follow-up from a previous episode published back in February called ‘Into the Flow: AKI Prevention with RenalGuard’, which centered around RenalGuard and the ability to prevent Acute Kidney Injury (AKI) through its use in percutaneous interventions.